Fundly.ai Secures $4 Million in Pre-Series A Funding
Mumbai-based Fundly.ai, a fintech platform tailored for India's pharmaceutical retail and distribution sector, has successfully raised $4 million in a Pre-Series A funding round. The round, which took place on September 8, 2026, was led by prominent investors Accel and Multiply, with participation from Rajeev Ahuja.
Company Overview
Fundly.ai provides integrated credit, commerce, and payment solutions specifically designed for the pharmaceutical industry in India. This sector-specific approach aims to streamline financial transactions and improve operational efficiency within pharma retail and distribution networks.
Leadership and Vision
The company was founded by Amit Chawla, who has been instrumental in steering Fundly.ai towards addressing the unique challenges faced by the pharmaceutical sector in India. By leveraging technology, Fundly.ai aims to enhance financial accessibility and efficiency for its clients.
Strategic Use of Funds
The newly acquired funds will be directed towards scaling the company’s infrastructure to better support its payment and commerce solutions. This expansion is expected to enhance the platform's capabilities, allowing it to serve a larger segment of India's pharmaceutical industry more effectively.
Investor Insights
Accel and Multiply, both leading investors in this round, have shown confidence in Fundly.ai's potential to transform the financial landscape of the pharmaceutical distribution sector in India. Rajeev Ahuja's involvement further underscores the belief in the company's growth trajectory.
This funding round marks a significant step for Fundly.ai as it continues to develop and expand its fintech offerings, aiming to play a pivotal role in modernizing financial processes within India's pharmaceutical sector.